Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blair, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blair, C. K.
Related Collections
Right arrow All Cognitive Disorders/Dementia
Right arrow Cognitive aging
Right arrow Cognitive neuropsychology in dementia
Right arrow Assessment of cognitive disorders/dementia
Right arrow MCI (mild cognitive impairment)
Right arrow Risk factors in epidemiology
NEUROLOGY 2005;64:268-276
© 2005 American Academy of Neurology

APOE genotype and cognitive decline in a middle-aged cohort

C. K. Blair, MPH, A. R. Folsom, MD, D. S. Knopman, MD, M. S. Bray, PhD, T. H. Mosley, PhD and E. Boerwinkle, PhD for the Atherosclerosis Risk in Communities (ARIC) Study Investigators

From the Division of Epidemiology (Dr. Folsom, C.K. Blair), School of Public Health, University of Minnesota, Minneapolis; Department of Neurology (Dr. Knopman), Mayo Clinic, Rochester, MN; Children’s Nutrition Research Center (Dr. Bray), Department of Pediatrics, Baylor College of Medicine, Houston; Department of Medicine (Geriatrics) (Dr. Mosley), University of Mississippi Medical Center, Jackson; and Human Genetics Center and Institute of Molecular Medicine (Dr. Boerwinkle), Houston Health Sciences Center, University of Texas, Houston.

Address correspondence and reprint requests to Dr. A.R. Folsom, Division of Epidemiology, University of Minnesota, 1300 S. Second St., Suite 300, Minneapolis, MN 55454; e-mail: folsom{at}epi.umn.edu

Background: Most longitudinal studies of nondemented persons have reported greater cognitive decline among APOE {epsilon}4 carriers vs noncarriers. However, most studies involved elderly samples (aged 65+) and were not large enough to examine the three APOE alleles separately.

Methods: Change in cognitive function was examined over a 6-year period using three neuropsychological tests among four APOE genotype groups ({epsilon}2/2 + {epsilon}2/3, {epsilon}3/3 (referent), {epsilon}4/2 + {epsilon}4/3, {epsilon}4/4). The population-based sample included 1,693 African Americans and 6,202 Caucasians initially ages 47 to 68.

Results: There was increasingly greater cognitive decline from the {epsilon}2 group to the {epsilon}4/4 group in Caucasians for two of the three tests. The combination of APOE {epsilon}4 with hypercholesterolemia or diabetes showed the greatest cognitive decline. Among African Americans, only the test measuring psychomotor speed showed associations with APOE genotype.

Conclusions: APOE {epsilon}4 is associated with greater cognitive decline in middle-aged Caucasian individuals, with a reduced decline among {epsilon}2 carriers. This suggests that the processes by which APOE genotype mediates dementia risk are operative well in advance of overt dementia.


Supported by contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022 from the National Heart, Lung, and Blood Institute, NIH, as well as by contracts UR6/CCU617218 and HL073366.

Received May 10, 2004. Accepted in final form October 8, 2004.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
B. K. Lee, T. A. Glass, G. S. Wand, M. J. McAtee, K. Bandeen-Roche, K. I. Bolla, and B. S. Schwartz
Apolipoprotein E Genotype, Cortisol, and Cognitive Function in Community-Dwelling Older Adults
Am J Psychiatry, November 1, 2008; 165(11): 1456 - 1464.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. R. Schultz, M. J. Lyons, C. E. Franz, M. D. Grant, C. Boake, K. C. Jacobson, H. Xian, G. D. Schellenberg, S. A. Eisen, and W. S. Kremen
Apolipoprotein E genotype and memory in the sixth decade of life
Neurology, May 6, 2008; 70(19_Part_2): 1771 - 1777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. A Beydoun, J. S Kaufman, J. A Satia, W. Rosamond, and A. R Folsom
Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1103 - 1111.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Borroni, S. Archetti, M. Ferrari, B. M. Cesana, A. Padovani, C. E. Regan, C. Katona, Z. Walker, and G . Livingston
Relationship of vascular risk to the progression of Alzheimer disease
Neurology, March 27, 2007; 68(13): 1083 - 1084.
[Full Text] [PDF]


Home page
NeurologyHome page
H. A. Wishart, A. J. Saykin, T. W. McAllister, L. A. Rabin, B. C. McDonald, L. A. Flashman, R. M. Roth, A. C. Mamourian, G. J. Tsongalis, and C. H. Rhodes
Regional brain atrophy in cognitively intact adults with a single APOE {varepsilon}4 allele.
Neurology, October 10, 2006; 67(7): 1221 - 1224.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. C. Johnson, T. W. Schmitz, M. A. Trivedi, M. L. Ries, B. M. Torgerson, C. M. Carlsson, S. Asthana, B. P. Hermann, and M. A. Sager
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
J. Neurosci., May 31, 2006; 26(22): 6069 - 6076.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
G. E. Swan, C. N. Lessov-Schlaggar, D. Carmelli, G. D. Schellenberg, and A. La Rue
Apolipoprotein E {epsilon}4 and Change in Cognitive Functioning in Community-Dwelling Older Adults
J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 196 - 201.
[Abstract] [PDF]


Home page
NeurologyHome page
D. S. Knopman, T. H. Mosley, D. J. Catellier, A. R. Sharrett, and for the Atherosclerosis Risk in Communities (ARIC)
Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort
Neurology, September 27, 2005; 65(6): 876 - 881.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.